Marcel O. Bonn‐Miller

ORCID: 0000-0001-5088-5386
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cannabis and Cannabinoid Research
  • Substance Abuse Treatment and Outcomes
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Posttraumatic Stress Disorder Research
  • Child and Adolescent Psychosocial and Emotional Development
  • Sleep and related disorders
  • Homelessness and Social Issues
  • Behavioral Health and Interventions
  • Suicide and Self-Harm Studies
  • Mental Health Treatment and Access
  • Sleep and Wakefulness Research
  • Diet, Metabolism, and Disease
  • Migration, Health and Trauma
  • Smoking Behavior and Cessation
  • Forensic Toxicology and Drug Analysis
  • Psychedelics and Drug Studies
  • Resilience and Mental Health
  • Religion, Spirituality, and Psychology
  • Prenatal Substance Exposure Effects
  • Neurotransmitter Receptor Influence on Behavior
  • GABA and Rice Research
  • Mindfulness and Compassion Interventions
  • Bipolar Disorder and Treatment
  • Child Abuse and Trauma
  • Mental Health Research Topics

Charlotte's Web (United States)
2023-2025

Zynerba Pharmaceuticals (United States)
2017-2022

University of Arkansas at Fayetteville
2022

TWT GmbH Science & Innovation (Germany)
2022

University of Pennsylvania
2013-2021

VA Palo Alto Health Care System
2009-2020

National Center for PTSD
2010-2020

Philadelphia VA Medical Center
2012-2020

Center for Innovation
2013-2020

Thomas Jefferson University
2019

Objectives: Little research has investigated the demographic and symptom profile of medical cannabis users in states USA that have legalized use. Methods: In present cross-sectional study, we 217 adults currently receiving cannabis, as well differences problematic use perceived helpfulness terms (i) symptoms psychological disorders pain, (ii) motives for Results: Findings indicated perceive to be beneficial multiple conditions, some which is not specifically prescribed or allowed at state...

10.3109/00952990.2013.821477 article EN The American Journal of Drug and Alcohol Abuse 2013-11-08

Abstract Despite initial evidence linking distress tolerance to posttraumatic stress disorder (PTSD) symptom severity, there is a need for the investigation of interrelations among multiple measures and PTSD severity. Therefore, present study investigated concurrent relations tolerance, as well between these within trauma‐exposed community sample. The sample consisted 81 adults (63.1% women). Results indicated that Distress Tolerance Scale (Simons & Gaher, 2005 ) scores, but no other...

10.1002/jts.20568 article EN Journal of Traumatic Stress 2010-09-16

The present investigation, conducted between 2005 and 2006, examined the relation emotion dysregulation motives for marijuana use among 136 (71 women; Mage = 20.61 years) young adult smokers. As expected, after covarying theoretically relevant variables, DERS–total score was significantly related to coping motives, but no other use. Further analysis indicated that Non-acceptance of Emotional Responses subscale DERS accounted DERS-total effect. Results are discussed in better understanding...

10.1080/10826080802241292 article EN Substance Use & Misuse 2008-01-01

The present study examined the relations between posttraumatic stress disorder (PTSD) and cannabis use in a large representative survey of adults (N = 5,672) from United States (Kessler et al., 2004). After adjusting for sociodemographic variables (i.e., age, marital status, ethnicity, education, income, sex), alcohol disorders, nicotine dependence, lifetime current (past year) PTSD diagnoses were associated with increased odds history as well past year daily use. Lifetime, but not current,...

10.1037/a0023076 article EN Psychology of Addictive Behaviors 2011-01-01

The present investigation examines anxiety sensitivity, distress tolerance, and fear reactivity to bodily sensations in relation Coping Conformity marijuana use motives among a sample of young adult users (n = 135; 46.7% women; Mage 20.45, SD 5.0). After controlling for current frequency (past 30 days), daily cigarette smoking rate, average volume alcohol used over the past year, negative affectivity, other motives, sensitivity was significantly uniquely associated with use. Distress...

10.1037/a0014961 article EN Experimental and Clinical Psychopharmacology 2009-02-01

The present investigation examined marijuana use, abuse, and dependence in relation to self-reported use behaviors motives, as well concurrent cigarette problematic alcohol among a sample of young adult current users (n = 200; 44.5% women; M(age) 21.48, SD 6.54). Preliminary results broadly indicated that more severe forms (eg, dependence) were associated with pattern behavior, polysubstance greater motivation for multiple reasons. Results are discussed better understanding the underlying...

10.3109/10550490903077705 article EN American Journal on Addictions 2009-09-01

Current conceptualizations suggest that individuals with Posttraumatic Stress Disorder (PTSD) over-utilize relatively ineffective emotion regulation strategies such as expressive suppression, and under-utilize effective cognitive reappraisal. In the first prospective investigation of association between use PTSD symptom severity among military veterans in residential treatment for PTSD, we found that: (1) at both intake discharge, suppression was associated more severe symptoms reappraisal...

10.1521/jscp.2013.32.3.296 article EN Journal of Social and Clinical Psychology 2013-02-27

The present investigation sought to document current rates and trends of cannabis use disorder (CUD) diagnoses among patients the Veterans Affairs Health Care System (VA) during fiscal years 2002, 2008, 2009. Results indicated that prevalence CUD within VA has increased more than 50% (from 0.66% 1.05%) over past 7 years. with a diagnosis but no other illicit SUD rose 115.41% 0.27% 0.58%) same time period. States laws allowing for legal medicinal purposes had significantly higher...

10.1037/a0027622 article EN Psychological Services 2012-05-08

In an effort to better understand factors that may explain prior findings of a positive relation between posttraumatic stress symptom severity and coping-oriented marijuana use motivation, the present study tested whether association coping motives is mediated by difficulties in emotion regulation. Participants were 79 (39 women; M(age) = 22.29 years, SD 6.99) community-recruited adults who reported (1) lifetime exposure at least one disorder Criterion A traumatic event (2) past 30 days....

10.1080/16506073.2010.525253 article EN Cognitive Behaviour Therapy 2011-02-19

Background and Objectives The present study is the first to explore links between PTSD cannabis use characteristics immediately prior a quit attempt, including motives, problems, withdrawal, craving. Methods Measures of diagnosis, symptom severity, were administered sample dependent military veterans ( n = 94). Hypotheses tested with series analyses variance covariance hierarchical multiple regressions Bonferroni corrections. Analyses conducted without adjusting for shared substance...

10.1111/j.1521-0391.2012.12018.x article EN American Journal on Addictions 2013-04-25

Research in community and clinical samples has documented elevated rates of cannabis use disorders (CUDs) among individuals with trauma exposure posttraumatic stress disorder (PTSD). However, there is a lack research investigating relations between, correlates of, phenotypes epidemiologic samples. The current study examined associations between (i.e., lifetime PTSD) CUD) nationally representative sample. Participants were who participated Waves 1 2 the National Epidemiologic Survey on...

10.1037/adb0000110 article EN other-oa Psychology of Addictive Behaviors 2015-09-01

Fragile X syndrome (FXS) is characterized by a range of developmental, neuropsychiatric, and behavioral symptoms that cause significant impairment in those with the disorder. Cannabidiol (CBD) holds promise as potential treatment for FXS due to its safety profile positive effects on number emotional associated FXS. The aim current study was evaluate safety, tolerability, initial efficacy ZYN002, transdermal CBD gel, pediatric population Twenty children adolescents (aged 6–17 years) diagnosis...

10.1186/s11689-019-9277-x article EN cc-by Journal of Neurodevelopmental Disorders 2019-08-02

There is a pressing need for development of novel pharmacology the treatment Posttraumatic Stress Disorder (PTSD). Given increasing use medical cannabis among US military veterans to self-treat PTSD, there strong public interest in whether may be safe and effective PTSD.The aim present study was collect preliminary data on safety potential efficacy three active concentrations smoked (i.e., High THC = approximately 12% < 0.05% CBD; CBD 11% 0.50% THC; THC+CBD 7.9% 8.1% CBD, placebo 0.03% 0.01%...

10.1371/journal.pone.0246990 article EN public-domain PLoS ONE 2021-03-17

<h3>Importance</h3> Products containing cannabinoids such as cannabidiol (CBD) have proliferated since 2018, when the Agriculture Improvement Act removed hemp (ie, cannabis &lt;0.3% Δ<sup>9</sup>-tetrahydrocannabinol [THC]) from US controlled substances list. Topical cannabinoid products can be purchased nationwide at retail stores and over internet, yet research on these is scarce. <h3>Objective</h3> To evaluate content CBD THC) label accuracy of topical to quantify their therapeutic...

10.1001/jamanetworkopen.2022.23019 article EN cc-by-nc-nd JAMA Network Open 2022-07-20
Coming Soon ...